Publication | Closed Access

An oral nano-antioxidant for targeted treatment of inflammatory bowel disease by regulating macrophage polarization and inhibiting ferroptosis of intestinal cells

InflammationNanomedicineAnti-inflammatoryTargeted TreatmentMacrophage PolarizationMedicineLipid PeroxidationImmunologyUlcerative ColitisReactive Oxygen SpeciePharmacologyCell BiologyOxidative StressExtracellular Matrix